In the Swiss Childhood Cancer Survivor Study, we aimed to assess the proportion of long-term survivors attending follow-up care, to characterise attendees and to describe the health professionals involved. We sent a questionnaire to 1252 patients, of whom 985 (79%) responded, aged in average 27years (range 20-49). Overall, 183 (19%) reported regular, 405 (41%) irregular and 394 (40%) no follow-up. For 344, severity of late effects had been classified in a previous medical examination. Only 17% and 32% of survivors with moderate and severe late effects respectively had made regular visits a decade later. Female gender, after a shorter time since diagnosis, had radiotherapy, and having suffered a relapse predicted follow-up. In the past year, 8% had seen a general practitioner only, 10% a paediatric or adult oncologist and 16% other health specialists for a cancer related problem. These findings underline the necessity to implement tailored national follow-up programmes. Only 17% and 32% of survivors with moderate and severe late effects respectively had regular visits a decade later. Female gender, a shorter time since diagnosis, radiotherapy, and having suffered a relapse predicted follow-up. In the past year, 8%
INTRODUCTION
Organization of long-term follow-up for childhood cancer survivors has become an important issue. Due to dramatic therapeutic improvements during past decades, survival rates in childhood cancer reached more than 80% (1) Little is known, if and how these recommendations are put into practice. Studies in the US, UK and Canada reported that contrary to recommendations, only one third of survivors received regular long-term follow-up. (11) (12) (13) In Switzerland and elsewhere, the implementation of follow-up programs for long-term survivors remains a challenge. The Swiss Paediatric Oncology Group (SPOG) has published recommendations for a standardized assessment of late effects in 1996 suggesting to involve medical oncologists and general practitioners to assure a seamless transition from paediatric to adult care.(5-6) However, it is unknown how these recommendations have been implemented into practice, what proportion of survivors really attend long-term follow-up and where they go. The Swiss health care system has a compulsory national health insurance, with premiums for disadvantaged citizens subsidized by the government. This should guarantee equal access to all treatments.
In this study, we aimed 1) to assess the proportion of long-term childhood cancer survivors attending follow-up, considering severity of late effects, 2) to characterize follow-up attendees and 3) identify the health professionals involved.
PATIENTS AND METHODS

Study population
The Swiss Childhood Cancer Registry (SCCR) is a population-based registry including all children and young people diagnosed with leukaemia, lymphoma, central nervous system (CNS) tumours, malignant solid tumours or Langerhans cell histiocytosis (LCH) before the age of 16 years. (14) (15) Nested in the SCCR, the Swiss Childhood Cancer Survivor Study (SCCSS) is a nationwide long-term follow-up study that started in 2007 and includes all registered patients who were diagnosed since 1976 and survived at least 5 years. For the current analysis we included all survivors aged 20 years or over at the time of survey, more than 10 years after diagnosis (n=1280).
A subgroup of eligible survivors (n=478) had participated in a standardized medical examination during the 1990s to detect late effects. (5, 16) The examination included medical history, clinical examination, neuropsychological testing and laboratory investigations. Severity of late effects was graded from 0 to 4 (see Appendix II: Table   1 for definitions and examples): with grade 0 "no late effects"; grade 1 "asymptomatic, not requiring therapy for late effects" (=mild, e.g. scar); grade 2 "late effects needing continuous medical follow-up" (=moderate, e.g. hypothyroidism); grade 3 "physical or mental sequelae, not likely to be improved by therapy" (=severe, e.g. cognitive deficits limiting schooling); and grade 4 "severely handicapping late effects, leaving patients unable to work independently" (=very severe). 
Procedure
All survivors received a study information letter from their former treating centre, with the option to decline, report address changes or request the questionnaire in another language (German, French and Italian). Survivors wishing to take part in the study were sent a copy of the questionnaire with a pre-paid return envelope. Reminder letters were sent to non-responders two months later. If they did not return the questionnaire at this stage, they were contacted by telephone to answer a shortened version.
Measures
Baseline demographic information together with prospectively collected medical information on diagnosis and treatment was extracted from the SCCR. Diagnosis was classified according to the International Classification of Childhood Cancer. (17) For the analysis, diagnostic groups with less than 5% survivors were merged. Treatment options included surgery only, chemotherapy (without radiotherapy, may have had surgery), radiotherapy (may have had surgery or chemotherapy), and participants were coded accordingly.
We used a standardized questionnaire derived from childhood cancer survivor studies in the US and UK. (18) (19) ) Furthermore, we included specific sociodemographic measures for comparison with the Swiss population. The main domains of the questionnaire were: quality of life, somatic health, current medication and health service utilization, psychological distress, health behaviour, and socioeconomic information.
To assess the proportion of survivors attending follow-up, we first asked whether they still attended follow-up for their cancer. Possible answers included: yes, at the treatment centre; yes, elsewhere (both coded as regular follow-up); no, but sees a doctor every now and then for a medical check-up (coded as irregular follow-up); and no, has not seen a doctor for a while. We also asked participants to select which health professionals they had seen in the past year from a list and whether these visits were related to cancer or not (Appendix II: Questions used in questionnaire (English translation); questionnaire is available at http://www.childhoodcancerregistry.ch/index.php?id=2849).
General health status and physical pain were measured with item 1 and item 7 of the Short Form 36 (SF36). (20) Survivors were also asked if they experienced any late effects of their cancer or treatment. Socio-economic status was measured by education. We grouped parents' and survivors' own education into four categories: "compulsory schooling", "vocational training", "upper secondary education" (including high school, teachers training colleges, technical colleges and upper vocational education) and "university education". Survivors were asked whether they had received recommendations for follow-up; either a medical checklist or a copy of their discharge letter. Furthermore, we asked if they had actively searched for further information on their former disease after discharge using any of the following sources: physician, internet, technical books or reports, friends, survivor associations or others.
Statistical analysis
We used Stata version 10 (Stata Corporation, Austin, Texas) for all analyses.
Differences between responders and non-responders were assessed using chi2-and Kruskal Wallis trend tests. Factors associated with attending follow-up in the univariate analysis (p<0.05) were assessed in two different logistic regression models. Firstly we included factors from the SCCR collected at the time of diagnosis.
In a second model, we looked at factors assessed in the survey simultaneously to the information on follow-up attendance, to characterize the attendees. Both models were also repeated using multinomial logistic regression comparing non-attendees with irregular and regular follow-up attendees separately.
RESULTS
Of the 1441 eligible survivors a valid address was found for 1252 (87%). Among these, 985 (79%) returned the questionnaire ( Figure 1 ) including 71 survivors who only answered the shortened questionnaire. Responders did not differ from nonresponders regarding diagnosis and therapy, but were more often female and German speaking (Table 1) . Response-rate varied across treatment centres from 71% to 88%. Survivors' mean age at the time of survey was 27.2 years (range 20 to 49 years) and the mean time elapsed since diagnosis was 20.6 years (10 to 44 years). 
Use of long-term follow-up by severity of late effects
Characteristics of follow-up attendees
Factors associated with use of follow-up were determined in two separate models.
First, we assessed which factors predicted follow-up attendance, by looking at information assessed at the time of diagnosis (Table 2) . Females were more likely to attend follow-up than males, (odds ratio (OR)=1.42). Survivors with more than 20 years since diagnosis were less likely to have follow-up than survivors with a shorter time since diagnosis (OR=0.48). Also treatment modalities predicted use of follow-up:
71% of survivors treated with radiotherapy and 54% of those with chemotherapy but no radiotherapy attended follow-up, compared to 42% of those with surgery only (OR=2.12 and 3.81). Survivors with a relapse history were more likely to attend (OR=1.92). Results were similar when comparing regular attendees and irregular attendees separately to non-attendees in a multinomial regression model, with somewhat larger effect sizes for regular attendees (Appendix II: Table 2 ).
Second, we examined characteristics of attendees assessed at the time of the survey (Table 3 ). In the multivariable model attendees were more likely to report late effects from their cancer treatment (OR=2.50) and to have actively sought for information about their former disease after discharge (OR=1.78; information from physician: 30% of attendees vs. 15% of non-attendees; internet: 20% vs. 14%; technical books/magazines: 21% vs. 12%). Socio-economic determinants such as level of education of survivors and having a partner were not associated. Results of the multinomial regression model were again comparable, with larger effect sizes for regular than for irregular attendees, when both were compared to non-attendees (Appendix II: Table 3 ).
Health care professionals involved in long-term follow-up
In total, 764 of 914 survivors (84%) reported having visited a health professional in the past year and 312 (34%) said that the visit had been caused by a problem related 
DISCUSSION
This nationwide long-term follow-up study found that only 19% of long-term survivors of childhood cancer had regular follow-up visits, with an additional 41% reporting irregular visits. Although the proportion of survivors attending follow-up increased with severity of late effects, only a minority of those judged as needing long-term follow-up at a previous medical examination still attended regular visits a decade later. In the past year 34% of survivors had sought medical help for a problem related to their former disease, most often from a general practitioner.
Comparison of the proportion of follow-up attendees with other countries
Direct comparisons are difficult since studies on use of follow-up included differing times elapsed since diagnosis (Appendix II: Table 4 In our study, the proportions of survivors having follow-up increased with severity of their late effects. In Switzerland and elsewhere an annual follow-up of all survivors might neither be possible nor necessary. A relatively simple three-level model of risk-stratification based on diagnosis and treatment has therefore been proposed. (24) Survivors with moderate or severe late effects are likely to profit from medical care in a regular follow-up. Similar to our findings, a recent report from the CCSS showed a higher probability to receive risk-based care for survivors with a severe, life threatening or disabling chronic health condition. (12) However, in our study, a substantial proportion of survivors, even those with moderate or severe late effects, which would require regular follow-up or therapy, reported to not attend ten years later.
Factors associated with follow-up
In accordance with studies from other countries, likelihood to attend follow-up decreased with longer time since diagnosis, (13, 22) Survivors from bone tumours were more likely to have seen an oncologist than survivors of leukaemia. (13) In contrast with other studies, we found that females were more likely to attend. (11-12, 23, 26-27) Survivors' educational background was not associated with follow-up attendance, as in other studies. (12, 22) Considering all this, it seems that problems associated with long-term follow-up are seen in different continents and different health care models, including health care systems that should guarantee equal access to treatment to all patients, including the poorest. This suggests that characteristics of the health systems may not be the most important barriers to access of follow-up for young adult survivors of childhood cancer.
Insufficient knowledge of survivors about their diagnosis, treatment and potential late consequences has been described as a major barrier to follow-up. (28) (29) We found that only 25% of study participants had ever received a written document with recommendations for future care. In addition, survivors' own interest in their disease, as shown by active search for further information, was strongly associated with follow-up attendance. Physicians should be aware of their role as important information source for long-term survivors. However, results also show that the Internet played an important role. Websites with evidence-based information specifically for survivors and ideally maintained by professionals therefore need to be developed.
Health professionals involved in follow-up
Different models have been proposed to facilitate the transition from paediatric to the adult care in childhood cancer survivors. (21) Our results showed that similar to the UK and US, general practitioners were frequently involved in long-term care of childhood cancer survivors and saw the largest number of patients (n=164, 26%). (11, 22) Thus, a follow-up model with general practitioners as gatekeepers transferring patients to specialists may cover best the needs of a majority of patients. However, preferences and views of survivors and physicians, as well as specific features of the health system need to be considered. A UK study for instance reported that survivors highly appreciated clinic-based cancer-specific care. (30) Many different health care professionals were involved in long-term follow-up of childhood cancer survivors in our study, but contrary to recommendations paediatric oncologists played a modest role.(5-6) Survivors of Hodgkin's lymphoma often consulted oncologists, while brain tumour survivors went to endocrinologists, neurologists, ophthalmologists and psychologists. These consultations at many different specialists highlight the need for close collaboration between physicians.
Specialized multidisciplinary survivor programs may cover these needs best.(31)
Methodological considerations
The SCCSS is a nationwide representative cohort study investigating long-term outcome of childhood cancer in Switzerland. The following limitations have to be considered: first, our data are self-reported. Survivor's opinions on whether or not health visits in the past year were cancer-related might not always correspond with the opinion of their health care providers. Second, the medical examination of the sub sample of study participants had been more than a decade before the current survey, and may not be representative for the entire study population. Some formerly asymptomatic patients may have developed late effects since, and severity grades may have increased rather than decreased over time as transient problems were not coded as late effects and severe conditions were unlikely to be improved by therapy.
Third, our study design, where follow-up care and health outcomes were assessed at the same survey, does not allow to draw conclusions as to whether frequency or type of follow-up does influence incidence and severity of subsequently occurring late effects. This important question needs to be studied in a truly prospective design. A major strength of the study is the population-based design, and the fact that we also assessed information on health care providers. The response rate was high, and our results should be representative for childhood cancer survivors in Switzerland, with some caution for children diagnosed before 1990 when the Swiss Childhood Cancer Registry was less complete. (32) Variation in the response rate across treatment centres may reflect cultural differences in the French and German speaking part of Switzerland rather than differences in diagnosis or treatment of patients.
Conclusion
The study gave an overview on medical care of childhood cancer survivors in Switzerland and provides a basis for future research. Less than a fifth of survivors attended follow-up regularly and about a third irregularly. Strikingly only 60% of survivors diagnosed with moderate late effects 10 years ago, judged as requiring continued follow-up, had really attended. This contrasts with recommendations, and reasons for this remain unclear. In future studies, we plan to assess opinions, preferences and needs of survivors and health care providers as a basis for developing a national follow-up program tailored to the needs and preferences of those concerned.
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